𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endotoxins inhibit endocytotic catabolism of low-density lipoproteins in Hep G2 cells

✍ Scribed by Wei Liao; Dr. Claes-Henrik Florén


Book ID
102849813
Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
871 KB
Volume
16
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


The effects of endotoxins on the uptake and degradation of low-density lipoproteins in Hep G2, a well-differentiated human hepatoma cell line, were studied. The results showed that incubation of Hep G2 cells with 125I-labeled low-density lipoprotein in the presence of endotoxins caused decreased uptake and degradation of 125I-labeled low-density lipoprotein. The inhibitory effects of endotoxins on the uptake and degradation of 125I-labeled low-density lipoprotein were dose and time dependent. With a monoclonal low-density lipoprotein receptor antibody, it was found that endotoxins interfered with both low-density lipoprotein receptor-mediated and non-low-density lipoprotein receptor-mediated uptake. If, however, the cells were pretreated with endotoxins for 1 or 24 hr and then incubated with new medium without endotoxins, no inhibitory effect on the subsequent uptake and degradation of 125I-labeled low-density lipoprotein occurred. Endotoxins had no toxic effects on Hep G2 cells as judged by [3H]thymidine incorporation and by determination of cell growth. Also, endotoxins did not under our experimental conditions induce oxidative modification of low-density lipoprotein. Furthermore, reisolated low-density lipoprotein that had previously been incubated with endotoxin was catabolized to a lower extent by Hep G2 cells than was control low-density lipoprotein. We speculate that the inhibitory effect of endotoxins on cellular low-density lipoprotein catabolism is due to the formation of endotoxin-low-density lipoprotein complexes, which interfere with the binding of low-density lipoprotein to the cell surface.


📜 SIMILAR VOLUMES


Cyclosporine inhibits catabolism of low-
✍ O A Rayyes; A Wallmark; C Florén 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

suppressive drugs and used in most transplantation centers to prevent organ rejection. It is a cyclic polypeptide, consisting of 11 amino acids and has a molecular weight of 1,202 The aim of this study was to elucidate the possible d. It is insoluble in water but soluble in many organic solcauses of